Outcome of Board Meeting held on May 28, 2025 for financial results for half year and financial year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Adeshwar Meditex Ltd approved and took on record the audited financial results for the half year and full financial year ended March 31, 2025, along with the audit report. The statutory auditors (J N Gupta & Co. LLP) issued an unmodified (clean) opinion on the financial results, indicating no qualifications or concerns. The company also disclosed details of related party transactions for the year. Adeshwar Meditex manufactures and trades medical products such as sterile wound dressings, gauze dressings, cotton products, medical bandages, antiseptics and first aid kits, and operates on the SME exchange.
The clean audit opinion is a positive signal for shareholders, suggesting the financial statements are free from material misstatements. The disclosed related party transactions (including director loans of ₹150 lakhs, director salaries, and purchases/sales with director-linked entities like Shivadesh Meditex and Moksha Biosurgicals) are routine for closely-held SME companies but worth monitoring for governance purposes.